CHEMM ChemoMetec

Preliminary revenue figures for the 2024/25 financial year

Preliminary revenue figures for the 2024/25 financial year

ANNOUNCEMENT NO. 290

1 July 2025

Preliminary revenue figures for the 2024/25 financial year

Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million for the financial year 2024/25, against the previously announced DKK 470-490 million.

ChemoMetec’s annual report for 2024/25 is scheduled to be released on 11 September 2025.

Additional information

Martin Helbo Behrens, CEO

Tel.: (+45) 48 13 10 20

Kim Nicolajsen, CFO

Tel.: (+45) 48 13 10 20

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements.

ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to .

Attachment



EN
01/07/2025

Underlying

CHEMMChemoMetec

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ChemoMetec

 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Opjustering

Opjustering MEDDELELSE NR. 295 28. oktober 2025 Opjustering ChemoMetec oplever en stigende interesse for sin teknologi, herunder ikke mindst XcytoMatic platformen, og forventer som følge heraf en positiv udvikling i salg og indtjening i særligt den sidste del af regnskabsåret 2025/26. Der forventes således nu en omsætning i regnskabsåret 2025/26 på DKK 565-580 mio. mod senest udmeldt DKK 545-565 mio. mens EBITDA forventes at ligge i intervallet DKK 320-335 mio. mod senest udmeldt DKK 295-315 mio. ChemoMetecs periodemeddelelse for 1. kvartal 2025/26 forventes offentliggjort den 6. nov...

October 28, 2025 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Upgrade of guidance

Upgrade of guidance ANNOUNCEMENT NO. 295 28 October 2025 Upgrade of guidance ChemoMetec experiences an increased interest in its technology, not the least the XcytoMatic platform, and consequently expects a positive trend in revenue and profit particularly in the last part of the financial year 2025/26. Consequently, revenue in the financial year 2025/26 is now expected to be DKK 565-580 million against the most recently announced DKK 545-565 million, while EBITDA is expected to be in the range of DKK 320-335 million compared to the most recently announced DKK 295-315 million. ChemoM...

October 28, 2025 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Forløb af ordinær generalforsamling

Forløb af ordinær generalforsamling MEDDELELSE NR. 294 9. oktober 2025 Forløb af ordinær generalforsamling Den ordinære generalforsamling i ChemoMetec A/S blev afholdt den 9. oktober 2025 kl. 17.30 hos Nordsjællands KonferenceCenter. På generalforsamlingen blev bestyrelsens beretning om selskabets virksomhed i det forløbne år fremlagt, årsrapporten for 2024/25 blev godkendt, og bestyrelsen samt direktionen blev meddelt decharge. Generalforsamlingen godkendte det af bestyrelsen fremsatte forslag om udlodning af udbytte på DKK 7 pr. aktie a nominelt DKK 1.  Bestyrelsens forslag om, ...

October 9, 2025 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Procedure of the Annual General Meeting

Procedure of the Annual General Meeting ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 9 October 2025 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of Directors' report on the company's activities during the past year was presented, the annual report for 2024/25 was approved, and the Board of Directors and the Executive Board were granted discharge. The Annual General Meeting approved the proposal of the Board of Directors to distribute a dividend of DKK ...

October 9, 2025 1 EN
 PRESS RELEASE
Free
CHEMM CHEMOMETEC

Notice of Annual General Meeting 2025

Notice of Annual General Meeting 2025 ANNOUNCEMENT NO. 293 17 September 2025 Notice of Annual General Meeting Notice is hereby given of the Annual General Meeting, which will be held on Thursday 9 October 2025 at 5.30 p.m. The general meeting will be held at Nordsjællands KonferenceCenter, Gydevang 39-41, 3450 Allerød Additional info Kim Nicolajsen, CFO Telefon (+45) 48 13 10 20 About ChemoMetec A/S ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, bi...

September 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch